The Fractalkine Receptor CX(3)CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular Remodeling.
The Fractalkine Receptor CX(3)CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular Remodeling.
复制标题
DOI:
10.3389/fimmu.2021.605857
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Spyridopoulos I
中科院分区:
文献类型:
--
作者:
Spray L;Park C;Cormack S;Mohammed A;Panahi P;Boag S;Bennaceur K;Sopova K;Richardson G;Stangl VM;Rech L;Rainer PP;Ramos GC;Hofmann U;Stellos K;Spyridopoulos I
Latent cytomegalovirus (CMV) infection is associated with adverse cardiovascular outcomes. Virus-specific CX3CR1+ effector memory T-cells may be instrumental in this process due to their pro-inflammatory properties. We investigated the role of CX3CR1 (fractalkine receptor) in CMV-related lymphocyte kinetics and cardiac remodeling in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). We retrospectively analysed lymphocyte count, troponin, and survival in 4874 STEMI/pPCI patients, evaluated lymphocyte kinetics during reperfusion in a prospective cohort, and obtained sequential cardiac MRI (cMRI) to assess remodeling. Pre-reperfusion lymphopenia independently predicted mortality at 7.5 years. Prior to reperfusion, CCR7+ T-lymphocytes appeared to be depleted. After reperfusion, T-lymphocytes expressing CX3CR1 were depleted predominantly in CMV-seropositive patients. During ischaemia/reperfusion, a drop in CX3CR1+ T-lymphocytes was significantly linked with microvascular obstruction in CMV+ patients, suggesting increased fractalkine-receptor interaction. At 12 weeks, CMV+ patients displayed adverse LV remodeling. We show that lymphopenia occurs before and after reperfusion in STEMI by different mechanisms and predicts long-term outcome. In CMV+ patients, increased fractalkine induction and sequestration of CX3CR1+ T-cells may contribute to adverse remodeling, suggesting a pro-inflammatory pathomechanism which presents a novel therapeutic target.
登录
查看更多内容
影响因子:
37.8
作者:
Siscovick, DS;Schwartz, SM;Kronmal, RA
通讯作者:
Kronmal, RA
影响因子:
11.3
作者:
Chia, Stanley;Senatore, Fred;Jang, Ik-Kyung
通讯作者:
Jang, Ik-Kyung
DOI:
10.1056/nejmoa1809798
发表时间:
2019-02-21
期刊:
The New England journal of medicine
影响因子:
--
作者:
Ridker PM;Everett BM;Pradhan A;MacFadyen JG;Solomon DH;Zaharris E;Mam V;Hasan A;Rosenberg Y;Iturriaga E;Gupta M;Tsigoulis M;Verma S;Clearfield M;Libby P;Goldhaber SZ;Seagle R;Ofori C;Saklayen M;Butman S;Singh N;Le May M;Bertrand O;Johnston J;Paynter NP;Glynn RJ;CIRT Investigators
通讯作者:
CIRT Investigators
DOI:
10.2353/ajpath.2010.090759
发表时间:
2010-05
期刊:
The American journal of pathology
影响因子:
--
作者:
Dobaczewski M;Xia Y;Bujak M;Gonzalez-Quesada C;Frangogiannis NG
通讯作者:
Frangogiannis NG
影响因子:
6.4
作者:
Libri, Valentina;Azevedo, Rita I.;Akbar, Arne N.
通讯作者:
Akbar, Arne N.